Table 3.
Standardized ileal digestible BCAA:Lys ratio in the experimental diets
Item | Target ratio | Calculated SID BCAA:Lys ratio adjusted by SBM | ||||
---|---|---|---|---|---|---|
PC* | NC | Grow | Finish | Grow–Finish | ||
Growing phase, (phase 1, phase 2) | ||||||
SID Val:Lys, % | 68, 68 | 68, 68 | 68, 68 | 73, 73 | 78, 81 | 73, 73 |
SID Ile:Lys, % | 60, 60 | 64, 62 | 59, 56 | 64, 61 | 70, 70 | 64, 61 |
SID Leu:Lys, % | 140–150 | 120, 120 | 136, 136 | 143, 143 | 150, 150 | 143, 143 |
Finishing phase, (phase 3, phase 4) | ||||||
SID Val:Lys, % | 78, 78 | 68, 68 | 69, 71 | 73, 75 | 82, 84 | 82, 84 |
SID Ile:Lys, % | 70, 70 | 60, 58 | 56, 56 | 61, 60 | 70, 70 | 70, 70 |
SID Leu:Lys, % | 150–170 | 131, 137 | 147, 159 | 153,164 | 165, 176 | 165, 176 |
Positive control (PC): a corn–SBM based diet with SID BCAA:Lys of PIC (2020) for the overall experimental period;
Negative control (NC): a cDDGS diet with SID BCAA:Lys of PIC (2020) for the overall experimental period;
A cDDGS diet with SID BCAA:Lys targeted for the growing phase for overall experimental period;
A cDDGS diet with SID BCAA:Lys targeted for the finishing phase for overall experimental period;
A cDDGS diet with SID BCAA:Lys targeted for the growing phase for phases 1 and 2 and SID BCAA:Lys targeted for the finishing phase for phases 3 and 4.